Mayo Clinic Laboratories > BioPharma Diagnostics > Testing > Gastroenterology

GastroenteroloGy

LEADING THE FIELD THROUGH PATIENT-CENTRIC TESTING

Mayo Clinic has been recognized as the No. 1 gastroenterology and gastrointestinal surgery hospital in the nation by U.S. News & World Report every year since 1990. Backed by the experience and knowledge of more than 140 digestive disease specialists, our disease-specific tests are clinically reinforced, cost-effective, and developed with patients in mind. The clinically actionable information enabled by these assays is a contributing factor in establishing Mayo Clinic's premier status in this area.

A collaboration with BioPharma Diagnostics includes access to Mayo Clinic Laboratories' robust gastroenterology test catalog, which features more than 330 tests to confirm diagnosis, monitor disease, and guide therapies. Whether performing routine serological testing or advanced biomarker evaluations, our tests enable insights to advance our partners' clinical trials goals.

To learn more about our testing, view our biopharma-specific test catalog and full test catalog.

Test menu

Full suite of gastroenterology testing Full suite of gastroenterology testing
Full suite of gastroenterology testing

Our integration with a world-renowned medical center equips us with patient experience that supports development of disease-specific, algorithmic-based testing approaches that provide faster answers for each patient. Whether screening patients or monitoring therapeutic management, our evaluations cover the full-spectrum of gastroenterology testing.

Autoimmune GI dysmotility Autoimmune GI dysmotility
Autoimmune GI dysmotility

Our serological assay for autoimmune GI dysmotility evaluates for antibody biomarkers that can clarify diagnosis and, in some cases, help direct the search for an underlying cancer.

Biologics management Biologics management
Biologics management

Our reflexive testing approach first measures the concentration of the biologic treatment within a patient’s specimen. Then, if necessary, an additional test is performed to assess the presence of antibodies to a specific drug that the patient has been receiving.

Celiac disease Celiac disease
Celiac disease

We have established several cascading algorithms to aid in the diagnosis of celiac disease. Automatic reflexing is performed only when necessary to find the right answer for patients and reduce costs.  

Inflammatory bowel disease Inflammatory bowel disease
Inflammatory bowel disease

Our robust menu of inflammatory bowel disease (IBD) testing includes calprotectin testing to diagnose IBD or irritable bowel syndrome (IBS); serologic testing to diagnose Crohn’s disease and ulcerative colitis; therapeutic monitoring of thiopurines; genetic testing to identify monogenic IBD; and biologics testing to measure immunogenicity and drug resistance.

Intestinal infections Intestinal infections
Intestinal infections

Our multiplex polymerase chain reaction panel detects the most common agents of bacterial, viral, and parasitic enteric infections directly from stool specimens.

Liver disease Liver disease
Liver disease

We offer a comprehensive menu of liver disease testing to evaluate for metabolic, viral, genetic, autoimmune, and cancerous causes of liver disease.

Malabsorption Malabsorption
Malabsorption

Including evaluations for bile acid malabsorption, pancreatic elastase testing, and disaccharidase testing, our malabsorption test menu can identify underlying causes and direct appropriate treatment. Developed to be as minimally invasive as possible, our malabsorption testing provides clarity on a complex condition.  

Pediatric Pediatric
Pediatric

Developed in collaboration with Mayo Clinic’s top-ranked GI experts, our comprehensive menu of disease-specific tests enables personalized answers to optimize outcomes for the youngest patients.

Comprehensive disease testing

A collaboration with BioPharma Diagnostics includes access to the gastroenterology disease testing capabilities of Mayo Clinic Laboratories, including:

  • Inflammatory bowel disease
  • Therapeutic drug monitoring
  • Intestinal infections
  • Chronic liver disease
  • Celiac disease
  • Pancreatic disease
  • Autoimmune testing
  • Metabolite monitoring
  • Noninvasive mucosal healing tests
  • Antibody testing

BioPharma Diagnostics partners can access gastroenterology testing for clinical trials and be among the first to use up-and-coming tests currently in development.

News and updates

The latest

Assay monitors response to monoclonal antibody therapy: Maria Alice Willrich, Ph.D.

Maria Alice Willrich, Ph.D., explains how Mayo Clinic Laboratories' new assay provides therapeutic drug monitoring of risankizumab, or RISA. Test results help guide care for patients with plaque psoriasis, psoriatic arthritis, and Crohn's disease.

Learn more
Infliximab Test Now Validated for Inflectra

Mayo Clinic has completed validation of its existing Infliximab Quantitation with Reflex to Antibodies to Infliximab, Serum test for the new biosimilar drug Inflectra. Clients[...]

Calprotectin and Inflammatory Bowel Disease

The differential diagnosis for inflammatory bowel disease (IBD) includes irritable bowel syndrome (IBS). While the clinical presentation is similar, IBD is an inflammatory disease, while IBS is a noninflammatory disease. View this "Hot Topic" to learn about testing for IBD and IBS.

Gastrointestinal Pathogen Panel, PCR, Feces [Test in Focus]

The new Gastrointestinal Pathogen Panel, PCR, Feces test is now available to the Mayo Clinic practice and Mayo Medical Laboratories clients.

<em>Helicobacter pylori</em> Infection: Serologic Testing Not Recommended [Communiqué]

Helicobacter pylori (H pylori) infection is among the most common bacterial infections worldwide with approximately one-half of the world’s population infected. Several invasive and noninvasive testing methods are available to detect H pylori infection.

INTERESTED IN LEARNING MORE?

Fill out the form below and one of our specialists will be in touch.

Are you a patient? Click here.